The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation
The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation
Recruiting · NCT07314047 · Registry updated 2026-01-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation | Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Fistula, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Vascular Fistula, arteriovenous hemangioma/malformation, cardiovascular disorder, congenital arteriovenous fistula, vascular disorder, vascular malformation | Recruiting | Not applicable | 2026-01-02 | NCT07314047 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| MicroPort NeuroTech Co., Ltd. | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Changhai Hospital | Shanghai | China | 4 |